{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:14:10Z","timestamp":1786997650979,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.transproceed.2018.11.007","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T18:58:05Z","timestamp":1546973885000},"page":"790-793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unusual Cystic Fibrosis Transmembrane Conductance Regulator Mutations and Liver Disease: A Case Series and Review of the Literature"],"prefix":"10.1016","volume":"51","author":[{"given":"H.H.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Mew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.S.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.A.","family":"Yazigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.M.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.11.007_bib1","first-page":"136","article-title":"Liver disease in cystic fibrosis","volume":"9","author":"Kobelska-Dubiel","year":"2014","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.transproceed.2018.11.007_bib2","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.dld.2009.07.022","article-title":"Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease","volume":"42","author":"Siano","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"suppl","key":"10.1016\/j.transproceed.2018.11.007_bib3","doi-asserted-by":"crossref","first-page":"12S15","DOI":"10.1016\/S0929-693X(17)30058-1","article-title":"Liver disease, gastrointestinal complications, nutritional management and feeding disorders in pediatric cystic fibrosis","volume":"23","author":"Debray","year":"2016","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.transproceed.2018.11.007_bib4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2018.11.007_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-1007159","article-title":"Liver and biliary problems in cystic fibrosis","volume":"18","author":"Colombo","year":"1998","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.transproceed.2018.11.007_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic fibrosis: current therapeutic targets and future approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.transproceed.2018.11.007_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2018.11.007_bib8","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0140-6736(03)13368-5","article-title":"Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study","volume":"361","author":"McKone","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2018.11.007_bib9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.transproceed.2018.11.007_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ppul.10117","article-title":"Effects of salmeterol on arterial oxyhemoglobin saturations in patients with cystic fibrosis","volume":"34","author":"Salvatore","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.transproceed.2018.11.007_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.121.1.55","article-title":"Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis","volume":"121","author":"Moss","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.transproceed.2018.11.007_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcf.2010.10.003","article-title":"Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial","volume":"10","author":"Konstan","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.transproceed.2018.11.007_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/adc.75.1.67","article-title":"Neonatal cholestasis as the presenting feature in cystic fibrosis","volume":"75","author":"Lykavieris","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.transproceed.2018.11.007_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmoldx.2015.06.010","article-title":"Cystic fibrosis: a review of associated phenotypes, use of molecular diagnostic approaches, genetic characteristics, progress, and dilemmas","volume":"18","author":"Brennan","year":"2016","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.transproceed.2018.11.007_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis","volume":"140","author":"Ooi","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2018.11.007_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2006.07.016","article-title":"Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis","volume":"131","author":"Blackman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2018.11.007_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc08-0466","article-title":"Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults","volume":"31","author":"Adler","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.transproceed.2018.11.007_bib18","doi-asserted-by":"crossref","first-page":"a009548","DOI":"10.1101\/cshperspect.a009548","article-title":"The influence of genetics on cystic fibrosis phenotypes","volume":"2","author":"Knowles","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.transproceed.2018.11.007_bib19","series-title":"Disease of liver and biliary system in children","first-page":"270","article-title":"Hepatobiliary disease in cystic fibrosis","author":"Colombo","year":"2008"},{"key":"10.1016\/j.transproceed.2018.11.007_bib20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s12098-012-0842-5","article-title":"Cystic fibrosis presenting with neonatal cholestasis simulating biliary atresia in a patient with a novel mutation","volume":"80","author":"Eminoglu","year":"2013","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.transproceed.2018.11.007_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/2249-4847.179911","article-title":"Duodenal atresia and neonatal cholestasis in R117H cystic fibrosis","volume":"5","author":"Harris","year":"2016","journal-title":"J\u00a0Clin Neonatol"},{"key":"10.1016\/j.transproceed.2018.11.007_bib22","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3346\/jkms.2008.23.5.912","article-title":"Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis","volume":"23","author":"Ko","year":"2008","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.transproceed.2018.11.007_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199506013322204","article-title":"Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens","volume":"332","author":"Chill\u00f3n","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2018.11.007_bib24","series-title":"GeneReviews\u00ae [Internet]","article-title":"Cystic fibrosis and congenital absence of the vas deferens","author":"Ong","year":"2001"},{"key":"10.1016\/j.transproceed.2018.11.007_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0888-7543(91)90504-8","article-title":"Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene","volume":"10","author":"Zielenski","year":"1991","journal-title":"Genomics"},{"key":"10.1016\/j.transproceed.2018.11.007_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.gastro.2010.10.045","article-title":"Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis","volume":"140","author":"Schneider","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2018.11.007_bib27","first-page":"29","article-title":"Paucity of biliary ducts: a rare etiology of neonatal cholestasis","volume":"6","author":"Figiel","year":"2012","journal-title":"J\u00a0Radiol Case Rep"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519300429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519300429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T17:11:55Z","timestamp":1555434715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519300429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0041134519300429"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.11.007","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unusual Cystic Fibrosis Transmembrane Conductance Regulator Mutations and Liver Disease: A Case Series and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}